2023 |
Kable A, Fraser S, Fullerton A, Hullick C, Palazzi K, Oldmeadow C, et al., 'Evaluation of the Effect of a Safe Medication Strategy on Potentially Inappropriate Medications, Polypharmacy and Anticholinergic Burden for People with Dementia: An Intervention Study.', Healthcare (Basel), 11 (2023) [C1]
|
|
Nova |
2022 |
Ramanathan SA, Ling R, Tattersall A, Ingold N, De Silva MS, Close S, Searles A, 'Impact assessment of the medical practice assisting (MPA) program in general practice in the hunter New England and central coast regions of Australia.', Hum Resour Health, 20 81 (2022) [C1]
|
|
Nova |
2022 |
Dunlop AJ, White B, Roberts J, Cretikos M, Attalla D, Ling R, et al., 'Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings', ADDICTION, 117 382-391 (2022) [C1]
|
|
Nova |
2022 |
Ling R, Giles M, Searles A, 'Budget impact analysis of a multifaceted nurse-led intervention to reduce indwelling urinary catheter use in New South Wales Hospitals.', BMC Health Serv Res, 22 1000 (2022) [C1]
|
|
Nova |
2022 |
da Silva PV, Kamper SJ, Robson E, Davidson SRE, Gleadhill C, Donald B, et al., '"Myths and Facts" Education Is Comparable to "Facts Only" for Recall of Back Pain Information but May Improve Fear-Avoidance Beliefs: An Embedded Randomized Trial', JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY, 52 586-594 (2022) [C1]
|
|
Nova |
2022 |
Thomas S, Williamson K, Ling R, Dolja-Gore X, Islam FM, Higgins H, et al., 'Tailoring childhood immunisation services in a socioeconomically disadvantaged community in New South Wales, Australia: a cost analysis.', Aust J Prim Health, 28 490-497 (2022) [C1]
|
|
|
2022 |
Ling R, White B, Roberts J, Cretikos M, Howard M, Haber PS, et al., 'Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model', BMC HEALTH SERVICES RESEARCH, 22 (2022) [C1]
|
|
Nova |
2021 |
Ling R, Giles M, Searles A, 'Administration of indwelling urinary catheters in four Australian Hospitals: cost-effectiveness analysis of a multifaceted nurse-led intervention', BMC HEALTH SERVICES RESEARCH, 21 (2021) [C1]
|
|
Nova |
2021 |
Kable A, Hullick C, Palazzi K, Oldmeadow C, Searles A, Ling R, et al., 'Evaluation of a safe medication strategy intervention for people with dementia with an unplanned admission: Results from the Safe Medication Strategy Dementia Study', Australasian Journal on Ageing, 40 356-365 (2021) [C1]
Objective: To evaluate whether a safe medication strategy compared with usual care, provided to people with dementia during an unplanned admission, reduces readmissions to hospita... [more]
Objective: To evaluate whether a safe medication strategy compared with usual care, provided to people with dementia during an unplanned admission, reduces readmissions to hospital and re-presentation to emergency departments within three months. Methods: A prospective, controlled pre-/post-trial conducted at two regional hospitals in New South Wales, Australia. Results: No treatment effect was seen for time to first re-presentation or readmission within three months (P¿=.3). Compliance with six strategies applicable for all participants in the intervention phase was 58%. There was no treatment effect for secondary outcomes including dose administration aid use, home medicines review (HMR) requests by general practitioners and completed HMRs; however, they were significantly higher at the intervention site in both phases. Conclusion: A bundle of care to improve medication safety in people with dementia did not reduce re-presentations or readmissions within three months.
|
|
Nova |
2021 |
Robson E, Kamper SJ, Hall A, Lee H, Davidson S, da Silva PV, et al., 'Effectiveness of a Healthy Lifestyle Program (HeLP) for low back pain: statistical analysis plan for a randomised controlled trial', TRIALS, 22 (2021)
|
|
|
2020 |
Bruce R, Murdoch W, Kable A, Palazzi K, Hullick C, Pond D, et al., 'Evaluation of Carer Strain and Carer Coping with Medications for People with Dementia after Discharge: Results from the SMS Dementia Study', HEALTHCARE, 8 (2020) [C1]
|
|
Nova |
2020 |
Giles M, Graham L, Ball J, King J, Watts W, Harris A, et al., 'Implementation of a multifaceted nurse-led intervention to reduce indwelling urinary catheter use in four Australian hospitals: A cluster controlled study.', Journal of clinical nursing, 29 872-887 (2020) [C1]
|
|
Nova |
2020 |
Fehily C, Ling R, Searles A, Bartlem K, Wiggers J, Hodder R, et al., 'An economic evaluation of a specialist preventive care clinician in a community mental health service: A randomised controlled trial', BMC Health Services Research, 20 (2020) [C1]
|
|
Nova |
2020 |
Rush A, Catchpoole DR, Ling R, Searles A, Watson PH, Byrne JA, 'Improving Academic Biobank Value and Sustainability Through an Outputs Focus', Value in Health, 23 1072-1078 (2020) [C1]
|
|
Nova |
2019 |
Ling R, Searles A, Hewitt J, Considine R, Turner C, Thomas S, et al., 'Cost analysis of an integrated aged care program for residential aged care facilities', Australian Health Review, 43 261-267 (2019) [C1]
Objective: To compare annual costs of an intervention for acutely unwell older residents in residential age care facilities (RACFs) with usual care. The intervention, the Aged Car... [more]
Objective: To compare annual costs of an intervention for acutely unwell older residents in residential age care facilities (RACFs) with usual care. The intervention, the Aged Care Emergency (ACE) program, includes telephone clinical support aimed to reduce avoidable emergency department (ED) presentations by RACF residents. Methods: This costing of the ACE intervention examines the perspective of service providers: RACFs, Hunter Medicare Local, the Ambulance Service of New South Wales, and EDs in the Hunter New England Local Health District. ACE was implemented in 69 RACFs in the Hunter region of NSW, Australia. Analysis used 14 weeks of ACE and ED service data (June-September 2014). The main outcome measure was the net cost and saving from ACE compared with usual care. It is based on the opportunity cost of implementing ACE and the opportunity savings of ED presentations avoided. Results: Our analysis estimated that 981 avoided ED presentations could be attributed to ACE annually. Compared with usual care, ACE saved an estimated A$921 214. Conclusions: The ACE service supported a reduction in avoidable ED presentations and ambulance transfers among RACF residents. It generated a cost saving to health service providers, allowing reallocation of healthcare resources. What is known about the topic?: Residents from RACFs are at risk of further deterioration when admitted to hospital, with high rates of delirium, falls, and medication errors. For this cohort, some conditions can be managed in the RACF without hospital transfer. By addressing avoidable presentations to EDs there is an opportunity to improve ED efficiency as well as providing care that is consistent with the resident's goals of care. RACFs generate some avoidable ED presentations for residents who may be more appropriately treated in situ. What does this paper add?: Telephone triaging with nursing support and training is a means by which ED presentations from RACFs can be reduced. One of the consequences of this intervention is 'cost avoided', largely through savings on ambulance costs. What are the implications for practitioners?: Unnecessary transfer from RACFs to ED can be avoided through a multicomponent program that includes telephone support with cost-saving implications for EDs and ambulance services.
|
|
Nova |
2018 |
Major GAC, Ling R, Searles A, Niddrie F, Kelly A, Holliday E, et al., 'The Costs of Confronting Osteoporosis: Cost Study of an Australian Fracture Liaison Service', Journal of Bone and Mineral Research Plus, 3 56-63 (2018) [C1]
|
|
Nova |
2018 |
Ling R, Rush A, Carter C, Carpenter J, Watson PH, Byrne JA, Searles A, 'An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks', Biopreservation and Biobanking, 16 53-58 (2018) [C1]
Biobanks face increasing demands for research materials of consistent quality, which can be used in collaborative studies. Several countries and some international agencies have m... [more]
Biobanks face increasing demands for research materials of consistent quality, which can be used in collaborative studies. Several countries and some international agencies have made formal efforts to standardize biobank operations and outputs. These include the establishment of best practice guidelines for collection management, and certification programs. Such guidelines and programs increase biobanks' opportunities for participation in high impact research and funding. However, they also impose economic and time costs, which may burden biobanks. This study aimed to estimate the costs of gaining certification and maintaining certification (i.e., committing extra resources to continue standards) for three cancer biobanks participating in a biobank certification program in New South Wales, Australia. To gather cost data for a range of cancer biobanks, we recruited three with different full time equivalent (FTE) staff levels (1.0-3.0), recognizing FTE staff level as an indicator of resources and operating scale. In extended interviews with staff, we gathered biobanks' expected costs in obtaining and annually maintaining certification. The biobank with the highest staff level reported the lowest expected costs in gaining certification, due to the strong prealignment of its present operations with certification requirements. The other biobanks expected higher costs as their operations required greater adjustments. Overall, relative costs of gaining certification were between 2% and 6% of current total annual wage costs. To the authors' knowledge, this is the first such costing study of a biobank certification program. Supplementary Data include the interview schedule that other biobanks may use to estimate their own economic certification costs.
|
|
Nova |
2018 |
Rush A, Ling R, Carpenter JE, Carter C, Searles A, Byrne JA, 'Research governance review of a negligible-risk research project: Too much of a good thing?', Research Ethics, 14 1-12 (2018) [C1]
|
|
Nova |
2018 |
Tzelepis F, Wiggers J, Paul CL, Byaruhanga J, Byrnes E, Bowman J, et al., 'A randomised trial of real-time video counselling for smoking cessation in regional and remote locations: study protocol', CONTEMPORARY CLINICAL TRIALS, 74 70-75 (2018)
|
|
|
2018 |
Major GAC, Ling R, Searles A, Niddrie F, Kelly A, Holliday E, et al., 'The Costs of Confronting Osteoporosis: Cost Study of an Australian Fracture Liaison Service', Journal of Bone and Mineral Research Plus, (2018)
|
|
|
2018 |
Edmunds K, Ling R, Shakeshaft A, Doran C, Searles A, 'Systematic review of economic evaluations of interventions for high risk young people', BMC Health Services Research, 18 (2018) [C1]
|
|
Nova |
2016 |
Stewart Williams J, Ling R, Searles AM, Doran CM, Byles J, 'Identification of higher hospital costs and more frequent admissions among mid-aged Australian women who self-report diabetes mellitus', Maturitas, 90 58-63 (2016) [C1]
Objective To ascertain whether the hospital costs for mid-aged Australian women who self-reported diabetes mellitus (DM) and who had one or more hospital admission during an eight... [more]
Objective To ascertain whether the hospital costs for mid-aged Australian women who self-reported diabetes mellitus (DM) and who had one or more hospital admission during an eight and a half year period were higher than the hospital costs for other similarly aged non-DM women. Methods The sample comprised 2,392 mid-aged women, resident in New South Wales (NSW) Australia and participating in the Australian Longitudinal Study on Women's Health (ALSWH), who had any NSW hospital admissions during the eight and a half year period 1 July 2000 to 31 December 2008. Analyses were conducted on linked data from ALSWH surveys and the NSW Admitted Patient Data Collection (APDC). Hospital costs were compared for the DM and non-DM cohorts of women. A generalized linear model measured the association between hospital costs and self-reported DM. Results Eight and a half year hospital costs were 41% higher for women who self-reported DM in the ALSWH surveys (p < 0.0001). On average, women who self-reported DM had significantly (p < 0.0001) more hospital admissions (5.3) than women with no reported DM (3.4). The average hospital stay per admission was not significantly different between the two groups of women. Conclusions Self-reported DM status in mid-aged Australian women is a predictor of higher hospital costs. This simple measure can be a useful indicator for public policy makers planning early-stage interventions that target people in the population at risk of DM.
|
|
Nova |
2016 |
Doran CM, Ling R, Searles A, Hill P, 'Does evidence influence policy? Resource allocation and the Indigenous Burden of Disease study', Australian Health Review, 40 705-715 (2016) [C1]
Objective The Indigenous Burden of Disease (IBoD) report is the most comprehensive assessment of Indigenous disease burden in Australia. The aim of the present study was to invest... [more]
Objective The Indigenous Burden of Disease (IBoD) report is the most comprehensive assessment of Indigenous disease burden in Australia. The aim of the present study was to investigate the potential effect of the IBoD report on Australian Indigenous health policy, service expenditure and research funding. Findings have significance for understanding factors that may influence Indigenous health policy. Methods The potential effect of the IBoD report was considered by: (1) conducting a text search of pertinent documents published by the federal government, Council of Australian Governments and the National Health and Medical Research Council of Australia (NHMRC) and observing the quantity and quality of references to IBoD; (2) examining data on government Indigenous healthcare expenditure for trends consistent with the findings and policy implications of the IBoD report; and (3) examining NHMRC Indigenous grant allocation trends consistent with the findings and policy implications of the IBoD report. Results Of 110 government and NHMRC documents found, IBoD was cited in 27. Immediately after publication of the IBoD report, federal and state governments increased Indigenous health spending (relative to non-Indigenous), notably for community health and public health at the state level. Expenditure on Indigenous hospital separations for chronic diseases also increased. These changes are broadly consistent with the findings of the IBoD report on the significance of chronic disease and the need to address certain risk factors. However, there is no evidence that such changes had a causal connection with the IBoD study. After publication of the IBoD report, changes in NHMRC Indigenous research funding showed little consistency with the findings of the IBoD report. Conclusions The present study found only indirect and inconsistent correlational evidence of the potential influence of the IBoD report on Indigenous health expenditure and research funding. Further assessment of the potential influence of the IBoD report on Indigenous health policy will require more targeted research, including interviews with key informants involved in developing health policy. What is known about the topic? There are currently no publications that consider the potential effed of the IBoD study on Indigenous health expenditure and research funding. What does this paper add? This paper offers the first consideration of the potential effect of the IBoD report. It contains analyses of data from readily available sources, examining national expenditures on Indigenous health and NHMRC Indigenous research, before and after the publication of the IBoD report. What are the implications for practitioners? The paper is relevant to analysts interested in drivers of Indigenous health policy. Although it finds correlations between the release of the IBoD report and some subsequent health spending decisions, other factors should be investigated to better understand the complexity of processes that drive government efforts to improve Indigenous health.
|
|
Nova |
2016 |
Searles A, Doran C, Attia J, Knight D, Wiggers J, Deeming S, et al., 'An approach to measuring and encouraging research translation and research impact', HEALTH RESEARCH POLICY AND SYSTEMS, 14 (2016) [C1]
|
|
Nova |
2016 |
Doran CM, Ling R, Gullestrup J, Swannell S, Milner A, 'The impact of a suicide prevention strategy on reducing the economic cost of suicide in the new south wales construction industry', Crisis, 37 121-129 (2016) [C1]
Background: Little research has been conducted into the cost and prevention of self-harm in the workplace. Aims: To quantify the economic cost of self-harm and suicide among New S... [more]
Background: Little research has been conducted into the cost and prevention of self-harm in the workplace. Aims: To quantify the economic cost of self-harm and suicide among New South Wales (NSW) construction industry (CI) workers and to examine the potential economic impact of implementing Mates in Construction (MIC). Method: Direct and indirect costs were estimated. Effectiveness was measured using the relative risk ratio (RRR). In Queensland (QLD), relative suicide risks were estimated for 5-year periods before and after the commencement of MIC. For NSW, the difference between the expected (i.e., using NSW pre-MIC [2008-2012] suicide risk) and counterfactual suicide cases (i.e., applying QLD RRR) provided an estimate of potential suicide cases averted in the post-MIC period (2013-2017). Results were adjusted using the average uptake (i.e., 9.4%) of MIC activities in QLD. Economic savings from averted cases were compared with the cost of implementing MIC. Results: The cost of self-harm and suicide in the NSW CI was AU $527 million in 2010. MIC could potentially avert 0.4 suicides, 1.01 full incapacity cases, and 4.92 short absences, generating annual savings of AU $3.66 million. For every AU $1 invested, the economic return is approximately AU $4.6. Conclusion: MIC represents a positive economic investment in workplace safety.
|
|
Nova |
2016 |
Edmunds K, Searles A, Neville J, Ling R, McCalman J, Mein J, 'Apunipima baby basket program: a retrospective cost study', BMC Pregnancy and Childbirth, 16 (2016) [C1]
|
|
Nova |
2016 |
Doran CM, Ling R, Byrnes J, Crane M, Shakeshaft AP, Searles A, Perez D, 'Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia', PLOS ONE, 11 (2016) [C1]
|
|
Nova |
2016 |
Ling R, Kelly B, Considine R, Tynan R, Searles A, Doran CM, 'The economic impact of psychological distress in the Australian coal mining industry', Journal of Occupational and Environmental Medicine, 58 e171-e176 (2016) [C1]
Objective: The aim of this study was to estimate the economic impact of psychological distress among employees of the Australian Coal Mining Industry. Methods: Sample data were ga... [more]
Objective: The aim of this study was to estimate the economic impact of psychological distress among employees of the Australian Coal Mining Industry. Methods: Sample data were gathered from 1456 coal mining staff across eight sites in two Australian states. Two measures were taken of work time lost over four weeks due to psychological distress: (1) full-day absences; (2) presenteeism. Lost work time was valued using hourly wages. Sample data was modeled to estimate annual monetary losses for the Australian Coal Mining Industry. Results: For the sample, estimated annual value of time lost due to psychological distress was $4.9 million ($AUS2015) ($0.61 million per mine), and for the Australian Coal Mining Industry, $153.8 million ($AUS2015). Conclusion: Psychological distress is a significant cost for the Australian Coal Mining Industry. Relevant intervention programs are potentially cost-effective.
|
|
Nova |
2015 |
Doran CM, Ling R, Byrnes J, Crane M, Searles A, Perez D, Shakeshaft A, 'Estimating the economic costs of skin cancer in New South Wales, Australia', BMC Public Health, 15 1-10 (2015) [C1]
|
|
Nova |
2014 |
Nair BKR, Searles AM, Ling RI, Wein J, Ingham K, 'Workplace-based assessment for international medical graduates: At what cost?', Medical Journal of Australia, 200 41-44 (2014) [C1]
Objective: To estimate the cost of resources required to deliver a program to assess international medical graduates (IMGs) in Newcastle, Australia, known as the Workplace Based A... [more]
Objective: To estimate the cost of resources required to deliver a program to assess international medical graduates (IMGs) in Newcastle, Australia, known as the Workplace Based Assessment (WBA) Program. Design and setting: A costing study to identify and evaluate the resources required and the overheads of delivering the program for a cohort of 15 IMGs, based on costs in 2012. Main outcome measures: Labour-related costs. Results: The total cost in 2012 for delivering the program to a typical cohort of 15 candidates was $243 384. This equated to an average of $16226 per IMG. After allowing for the fees paid by IMGs, the WBA Program had a deficit of $153384, or $10226 per candidate, which represents the contribution made by the health system. Conclusion: The cost per candidate to the health system of this intensive WBA program for IMGs is small.
|
|
Nova |